{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:56:38Z","timestamp":1785894998188,"version":"3.56.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajconline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.amjcard.2023.05.024","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T19:43:32Z","timestamp":1686858212000},"page":"171-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Management of Atrial Fibrillation Post Transcatheter Aortic Valve Implantation"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8155-603X","authenticated-orcid":false,"given":"Sandeep","family":"Banga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George S.","family":"Abela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Saltiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Fischell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadeesh K.","family":"Kalavakunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Najib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haya","family":"Al-Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Qintar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Bazil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashbir","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2023.05.024_bib0001","first-page":"468","article-title":"Predictors and clinical implications of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation","volume":"85","author":"Barbash","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0002","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jacc.2011.09.061","article-title":"Incidence, predictive factors, and prognostic value of new-onset atrial fibrillation following transcatheter aortic valve implantation","volume":"59","author":"Amat-Santos","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0003","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijcard.2015.10.133","article-title":"New-onset atrial fibrillation and increased mortality after transcatheter aortic valve implantation: a causal or spurious association?","volume":"203","author":"Gargiulo","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0004","doi-asserted-by":"crossref","first-page":"e1047","DOI":"10.4244\/EIJY15M11_12","article-title":"A meta-analysis of the impact of pre-existing and new-onset atrial fibrillation on clinical outcomes in patients undergoing transcatheter aortic valve implantation","volume":"12","author":"Sannino","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/CIRCINTERVENTIONS.112.000124","article-title":"Atrial fibrillation and aortic stenosis: impact on clinical outcomes among patients undergoing transcatheter aortic valve implantation","volume":"6","author":"Stortecky","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0006","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jcin.2016.01.037","article-title":"Prevalence and impact of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis from the SOURCE XT prospective multicenter registry","volume":"9","author":"Tarantini","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0007","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.jcin.2019.06.019","article-title":"Impact of pre-existing and new-onset atrial fibrillation on outcomes after transcatheter aortic valve replacement","volume":"12","author":"Mentias","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0008","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320949068","article-title":"Optimal antithrombotic therapy after transcatheter aortic valve replacement in patients with atrial fibrillation","volume":"11","author":"Zeng","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0009","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamainternmed.2019.0205","article-title":"Evaluation of the incidence of new-onset atrial fibrillation after aortic valve replacement","volume":"179","author":"Kalra","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0010","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacc.2006.10.062","article-title":"Mortality trends in patients diagnosed with first atrial fibrillation: a 21-year community-based study","volume":"49","author":"Miyasaka","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0011","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0012","first-page":"1285","article-title":"Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome","volume":"38","author":"Tarantini","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0013","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1016\/j.jcin.2018.05.042","article-title":"Incidence, management, and associated clinical outcomes of new-onset atrial fibrillation following transcatheter aortic valve replacement: an analysis from the STS\/ACC TVT registry","volume":"11","author":"Vora","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0014","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.amjcard.2018.12.041","article-title":"Incidence, predictors, management, and clinical significance of new-onset atrial fibrillation after transcatheter aortic valve implantation","volume":"123","author":"Yoon","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/CIRCINTERVENTIONS.115.002766","article-title":"Atrial fibrillation is associated with increased mortality in patients undergoing transcatheter aortic valve replacement: insights from the placement of aortic transcatheter valve (partner) trial","volume":"9","author":"Biviano","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0016","first-page":"407","article-title":"Assessment of inflammatory response to transfemoral transcatheter aortic valve implantation compared to transapical and surgical procedures: a pilot study","volume":"24","author":"St\u00e4hli","year":"2012","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0017","first-page":"180","article-title":"Causes of peri-operative mortality after transcatheter aortic valve implantation: a pooled analysis of 12 studies and 1223 patients","volume":"23","author":"Moreno","year":"2011","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0018","doi-asserted-by":"crossref","first-page":"B50","DOI":"10.1093\/eurheartj\/suz016","article-title":"Risk of stroke after transcatheter aortic valve implant: the role of the new oral anticoagulants","volume":"21","author":"Muscente","year":"2019","journal-title":"Eur Heart J Suppl"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0019","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1093\/eurheartj\/ehu175","article-title":"Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients","volume":"35","author":"Allende","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0020","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/clc.23178","article-title":"Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: insights from the Aristotle trial","volume":"42","author":"Guimar\u00e3es","year":"2019","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0021","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/CIRCULATIONAHA.116.026714","article-title":"ENGAGE AF-TIMI 48 Investigators. Edoxaban for the prevention of thromboembolism in patients with atrial fibrillation and bioprosthetic valves","volume":"135","author":"Carnicelli","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0022","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A controlled trial of Rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0023","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00392-018-1247-x","article-title":"NOAC monotherapy in patients with concomitant indications for oral anti-coagulation undergoing transcatheter aortic valve implantation","volume":"107","author":"Geis","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0024","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jcin.2016.10.023","article-title":"Apixaban in patients with atrial fibrillation after transfemoral aortic valve replacement","volume":"10","author":"Seeger","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2018.03.008","article-title":"Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: the randomized ATLANTIS trial","volume":"200","author":"Collet","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0026","unstructured":"Kumbhani DJ. Anti-thrombotic strategy to lower all cardiovascular and neurologic ischemic and hemorrhagic events after trans-aortic valve implantation for aortic stenosis; 2021. Available at:https:\/\/www.acc.org\/latest-in-cardiology\/clinical-trials\/2021\/05\/14\/01\/58\/atlantis#references-for-article. Accessed on December 6, 2022."},{"key":"10.1016\/j.amjcard.2023.05.024_bib0027","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2018.07.006","article-title":"Edoxaban versus standard of care and their effects on clinical outcomes in patients having undergone transcatheter aortic valve implantation in atrial fibrillation-rationale and design of the ENVISAGE-TAVI AF trial","volume":"205","author":"Van Mieghem","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0028","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","article-title":"Edoxaban versus vitamin K Antagonist for atrial fibrillation after TAVR","volume":"385","author":"Van Mieghem","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0029","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.amjcard.2011.07.049","article-title":"Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation","volume":"108","author":"Ussia","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0030","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ijcard.2014.04.170","article-title":"SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation","volume":"174","author":"Stabile","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0031","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jcin.2017.04.014","volume":"10","author":"Rod\u00e9s-Cabau","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0032","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.jcin.2016.06.025","article-title":"Warfarin and antiplatelet therapy versus warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement","volume":"9","author":"Abdul-Jawad Altisent","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0033","first-page":"1","article-title":"ACCF\/aATs\/SCAI\/STS expert consensus document on transcatheter aortic valve replacement","volume":"2012","author":"Holmes","year":"2012","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0034","first-page":"520","article-title":"Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement","volume":"28","author":"Webb","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0035","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jcin.2021.06.020","article-title":"Antithrombotic therapy after transcatheter aortic valve replacement","volume":"14","author":"Capodanno","year":"2021","journal-title":"JACC Cardiovasc Intv"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0036","first-page":"e35","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0037","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0038","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1056\/NEJMoa1602002","article-title":"Rate control versus rhythm control for atrial fibrillation after cardiac surgery","volume":"374","author":"Gillinov","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0039","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcin.2016.10.043","article-title":"Left atrial appendage thrombus in transcatheter aortic valve replacement: incidence, clinical impact, and the role of cardiac computed tomography","volume":"10","author":"Palmer","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.5761\/atcs.ra.18-00014","article-title":"The efficacy and safety of the WATCHMAN device in LAA occlusion in patients with non-valvular atrial fibrillation contraindicated to oral anticoagulation: a focused review","volume":"24","author":"Majule","year":"2018","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0041","unstructured":"Kapadia S. Watch-TAVR, Watchman for patients with atrial fibrillation undergoing transcatheter aortic valve replacement; 2021. Clinicaltrials.gov. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03173534. Accessed on December 6, 2022."},{"key":"10.1016\/j.amjcard.2023.05.024_bib0042","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199712183372501","article-title":"Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery","volume":"337","author":"Daoud","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0043","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0140-6736(00)04196-9","article-title":"Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomized placebo-controlled trial","volume":"357","author":"Giri","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0044","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1001\/jama.294.24.3093","article-title":"Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair: PAPABEAR: a randomized controlled trial","volume":"294","author":"Mitchell","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2023.05.024_bib0045","unstructured":"U.S. National Library of Medicine \u2013 ClinicalTrails.gov. Prevention of new-onset AF after TAVI (PAF-TAVI Trial) (PAF-TAVI). Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT03991754. Accessed on December 7, 2022."}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923003090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914923003090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:47:40Z","timestamp":1757573260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914923003090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":45,"alternative-id":["S0002914923003090"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.05.024","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Atrial Fibrillation Post Transcatheter Aortic Valve Implantation","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}